G. Cholewiński

1.0k total citations
39 papers, 737 citations indexed

About

G. Cholewiński is a scholar working on Molecular Biology, Organic Chemistry and Infectious Diseases. According to data from OpenAlex, G. Cholewiński has authored 39 papers receiving a total of 737 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Molecular Biology, 9 papers in Organic Chemistry and 8 papers in Infectious Diseases. Recurrent topics in G. Cholewiński's work include Biochemical and Molecular Research (15 papers), Renal Transplantation Outcomes and Treatments (8 papers) and HIV/AIDS drug development and treatment (8 papers). G. Cholewiński is often cited by papers focused on Biochemical and Molecular Research (15 papers), Renal Transplantation Outcomes and Treatments (8 papers) and HIV/AIDS drug development and treatment (8 papers). G. Cholewiński collaborates with scholars based in Poland, United Kingdom and United States. G. Cholewiński's co-authors include Krystyna Dzierzbicka, ALEKSANDER KOLODZIEJCZYK, Piotr Trzonkowski, Dorota Iwaszkiewicz‐Grześ, Janusz Rachoń, J. Cieślak, Sebastian Mucha, Agata Kot‐Wasik, E. Gus Cothran and Beata Krawczyk and has published in prestigious journals such as Chemical Communications, RSC Advances and European Journal of Medicinal Chemistry.

In The Last Decade

G. Cholewiński

38 papers receiving 723 citations

Peers

G. Cholewiński
James G. Robertson United States
Lainne E. Seitz United States
M. R. Atkinson Australia
Abdelaziz Mekhalfia United Kingdom
Eung Chil Choi South Korea
Sefer Baday Türkiye
Tomislav Karoli Australia
James G. Robertson United States
G. Cholewiński
Citations per year, relative to G. Cholewiński G. Cholewiński (= 1×) peers James G. Robertson

Countries citing papers authored by G. Cholewiński

Since Specialization
Citations

This map shows the geographic impact of G. Cholewiński's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by G. Cholewiński with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites G. Cholewiński more than expected).

Fields of papers citing papers by G. Cholewiński

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by G. Cholewiński. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by G. Cholewiński. The network helps show where G. Cholewiński may publish in the future.

Co-authorship network of co-authors of G. Cholewiński

This figure shows the co-authorship network connecting the top 25 collaborators of G. Cholewiński. A scholar is included among the top collaborators of G. Cholewiński based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with G. Cholewiński. G. Cholewiński is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Cholewiński, G., et al.. (2020). Immunosuppressive properties of amino acid and peptide derivatives of mycophenolic acid. European Journal of Medicinal Chemistry. 189. 112091–112091. 8 indexed citations
2.
Iwaszkiewicz‐Grześ, Dorota, G. Cholewiński, Agata Kot‐Wasik, Piotr Trzonkowski, & Krystyna Dzierzbicka. (2017). Investigations on the immunosuppressive activity of derivatives of mycophenolic acid in immature dendritic cells. International Immunopharmacology. 44. 137–142. 8 indexed citations
3.
Cholewiński, G., et al.. (2016). New Analogues of Mycophenolic Acid. Mini-Reviews in Medicinal Chemistry. 17(9). 734–745. 20 indexed citations
4.
Cholewiński, G., et al.. (2016). Synthesis of Combretastatin A-4 Analogs and their Biological Activities. Anti-Cancer Agents in Medicinal Chemistry. 16(8). 942–960. 17 indexed citations
5.
Dzierzbicka, Krystyna, et al.. (2015). Inhibitors of Angiogenesis in Cancer Therapy – Synthesis and Biological Activity. Current Medicinal Chemistry. 22(33). 3830–3847. 10 indexed citations
6.
Serocki, Marcin, et al.. (2015). Synthesis of functionalized new conjugates of batracylin with tuftsin/retro-tuftsin derivatives and their biological evaluation. European Journal of Medicinal Chemistry. 106. 85–94. 8 indexed citations
7.
Cieślak, J., et al.. (2013). Genotyping of coat color genes (MC1R, ASIP,PMEL17 and MATP) polymorphisms in cold-blooded horses bred in Poland reveals sporadic mistakes in phenotypic descriptions. Animal Science Papers and Reports. 31(2). 159–164. 6 indexed citations
8.
Iwaszkiewicz‐Grześ, Dorota, G. Cholewiński, Agata Kot‐Wasik, Piotr Trzonkowski, & Krystyna Dzierzbicka. (2013). Synthesis and biological activity of mycophenolic acid-amino acid derivatives. European Journal of Medicinal Chemistry. 69. 863–871. 30 indexed citations
9.
Cholewiński, G., et al.. (2012). Synthesis and biological activity of novel mycophenolic acid conjugates containing nitro-acridine/acridone derivatives. European Journal of Medicinal Chemistry. 54. 197–201. 29 indexed citations
10.
Cholewiński, G., Krystyna Dzierzbicka, & ALEKSANDER KOLODZIEJCZYK. (2011). Natural and synthetic acridines/acridones as antitumor agents: their biological activities and methods of synthesis. Pharmacological Reports. 63(2). 305–336. 130 indexed citations
11.
Cholewiński, G., et al.. (2011). 4-[(tert-Butyldimethylsilyl)oxy]-6-methoxy-7-methyl-5-(oxiran-2-ylmethyl)-2-benzofuran-3(1H)-one. Acta Crystallographica Section E Structure Reports Online. 67(12). o3393–o3393. 2 indexed citations
12.
Cholewiński, G., et al.. (2010). The Chemistry of Mycophenolic Acid - Synthesis and Modifications Towards Desired Biological Activity. Current Medicinal Chemistry. 17(18). 1926–1941. 19 indexed citations
13.
Cholewiński, G., Jarosław Chojnacki, Jerzy Pikies, & Janusz Rachoń. (2009). O-Pivaloyl diphenylselenophosphinate. Acta Crystallographica Section E Structure Reports Online. 65(4). o853–o854. 2 indexed citations
14.
Cholewiński, G., Jarosław Chojnacki, Jerzy Pikies, & Janusz Rachoń. (2009). O-4-Chlorobenzoyl diphenylselenophosphinate. Acta Crystallographica Section E Structure Reports Online. 65(4). o855–o855. 1 indexed citations
15.
Cholewiński, G., et al.. (2007). Reaction of thio and seleno phosphoric acid derivatives with O‐thioacylated hydroxylamine. Heteroatom Chemistry. 18(7). 767–773. 1 indexed citations
16.
Penedo, M. C. T., L. V. Millon, D Bernoco, et al.. (2005). International equine gene mapping workshop report: a comprehensive linkage map constructed with data from new markers and by merging four mapping resources. Cytogenetic and Genome Research. 111(1). 5–15. 58 indexed citations
17.
Pawlak, Michael, et al.. (2000). Study on the origin of 64,XX/63,X karyotype in four sterile mares.. Veterinární Medicína. 45. 299–301. 3 indexed citations
18.
Cholewiński, G., et al.. (1999). Absence of the severe combined immunodeficiency disease gene among Arabian horses in Poland. Journal of Applied Genetics. 40(1). 39–41. 6 indexed citations
19.
Świtoński, M., et al.. (1994). Preliminary investigation on inter-individual variation of the nucleolar organizer regions [Ag-NORs] in the horse karyotype. Animal Science Papers and Reports. 12(1). 15–19. 4 indexed citations
20.
Kurył, J., et al.. (1992). Genetic polimorphism of vitamin D binding protein and alpha one B-glycoprotein in blood serum of the Polish Primitive Horse [Konik]. Animal Science Papers and Reports. 9. 53–59.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026